Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 9
1964 8
1965 3
1966 2
1967 15
1968 15
1969 19
1970 22
1971 27
1972 19
1973 22
1974 23
1975 8
1976 11
1977 16
1978 13
1979 10
1980 17
1981 15
1982 8
1983 28
1984 24
1985 16
1986 13
1987 30
1988 28
1989 49
1990 45
1991 51
1992 43
1993 49
1994 48
1995 73
1996 47
1997 78
1998 56
1999 55
2000 71
2001 67
2002 65
2003 71
2004 85
2005 91
2006 90
2007 71
2008 57
2009 74
2010 99
2011 83
2012 93
2013 95
2014 96
2015 75
2016 63
2017 103
2018 90
2019 93
2020 88
2021 80
2022 79
2023 76
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

2,811 results

Results by year

Filters applied: . Clear all
Page 1
Personalized Management of Pheochromocytoma and Paraganglioma.
Nölting S, Bechmann N, Taieb D, Beuschlein F, Fassnacht M, Kroiss M, Eisenhofer G, Grossman A, Pacak K. Nölting S, et al. Endocr Rev. 2022 Mar 9;43(2):199-239. doi: 10.1210/endrev/bnab019. Endocr Rev. 2022. PMID: 34147030 Free PMC article. Review.
Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape that allows their assignment to clusters based on underlying genetic alterations. With around 30% to 35% of Caucasian patients (a lower percentage in the Chinese population) showing germline …
Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape that allows their assignment to clusters based on …
Pheochromocytoma.
Farrugia FA, Charalampopoulos A. Farrugia FA, et al. Endocr Regul. 2019 Jul 1;53(3):191-212. doi: 10.2478/enr-2019-0020. Endocr Regul. 2019. PMID: 31517632 Free article. Review.
Pheochromocytomas are rare tumors originating in the adrenal medulla. They may be sporadic or in the context of a hereditary syndrome. A considerable number of pheochromocytomas carry germline or somatic gene mutations, which are inherited in the autosomal dominant …
Pheochromocytomas are rare tumors originating in the adrenal medulla. They may be sporadic or in the context of a hereditary syndrome …
Pheochromocytoma, diagnosis and treatment: Review of the literature.
Farrugia FA, Martikos G, Tzanetis P, Charalampopoulos A, Misiakos E, Zavras N, Sotiropoulos D. Farrugia FA, et al. Endocr Regul. 2017 Jul 1;51(3):168-181. doi: 10.1515/enr-2017-0018. Endocr Regul. 2017. PMID: 28858847 Free article. Review.
OBJECTIVE: We conducted an extensive review of the literature and tried to cite the most recent recommendations concerning the pheochromocytoma (PHEO). METHODS: Pub Med and Google Scholar databases were searched systematically for studies concerning pheochromocytomas …
OBJECTIVE: We conducted an extensive review of the literature and tried to cite the most recent recommendations concerning the pheochromo …
Targeted Therapies in Pheochromocytoma and Paraganglioma.
Wang K, Crona J, Beuschlein F, Grossman AB, Pacak K, Nölting S. Wang K, et al. J Clin Endocrinol Metab. 2022 Nov 23;107(11):2963-2972. doi: 10.1210/clinem/dgac471. J Clin Endocrinol Metab. 2022. PMID: 35973976 Free PMC article. Review.
Molecular targeted therapy plays an increasingly important role in the treatment of metastatic pheochromocytomas and paragangliomas (PPGLs), which are rare tumors but remain difficult to treat. ...
Molecular targeted therapy plays an increasingly important role in the treatment of metastatic pheochromocytomas and paragangliomas ( …
Phaeochromocytoma.
Lenders JW, Eisenhofer G, Mannelli M, Pacak K. Lenders JW, et al. Lancet. 2005 Aug 20-26;366(9486):665-75. doi: 10.1016/S0140-6736(05)67139-5. Lancet. 2005. PMID: 16112304 Review.
Phaeochromocytomas are rare neuroendocrine tumours with a highly variable clinical presentation but most commonly presenting with episodes of headaches, sweating, palpitations, and hypertension. ...After the use of appropriate preoperative treatment to block the effects of …
Phaeochromocytomas are rare neuroendocrine tumours with a highly variable clinical presentation but most commonly presenting with epi …
Perioperative Management of Pheochromocytoma.
Naranjo J, Dodd S, Martin YN. Naranjo J, et al. J Cardiothorac Vasc Anesth. 2017 Aug;31(4):1427-1439. doi: 10.1053/j.jvca.2017.02.023. Epub 2017 Feb 4. J Cardiothorac Vasc Anesth. 2017. PMID: 28392094 Review.
Pheochromocytomas are rare neuroendocrine tumors that produce and store catecholamines. ...This review focuses on the perioperative management of pheochromocytoma/paragangliomas, initially summarizing the clinical aspects of the disease and then highlighting the cur …
Pheochromocytomas are rare neuroendocrine tumors that produce and store catecholamines. ...This review focuses on the perioperative m …
Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.
Jain A, Baracco R, Kapur G. Jain A, et al. Pediatr Nephrol. 2020 Apr;35(4):581-594. doi: 10.1007/s00467-018-4181-2. Epub 2019 Jan 2. Pediatr Nephrol. 2020. PMID: 30603807 Review.
Pheochromocytomas and paragangliomas (PPGLs) generally grouped together are rare catecholamine-secreting endocrine tumors. ...
Pheochromocytomas and paragangliomas (PPGLs) generally grouped together are rare catecholamine-secreting endocrine tumors. ...
Anesthesia for Endocrine Emergencies.
Peramunage D, Nikravan S. Peramunage D, et al. Anesthesiol Clin. 2020 Mar;38(1):149-163. doi: 10.1016/j.anclin.2019.10.006. Epub 2020 Jan 2. Anesthesiol Clin. 2020. PMID: 32008649 Review.
The most common critical endocrine abnormalities are associated with functional tumors, such as pheochromocytomas, insulinomas, and carcinoid tumors, leading to carcinoid syndrome, abnormal thyroid function, or disturbances in the hypothalamus-pituitary-adrenal axis, causi …
The most common critical endocrine abnormalities are associated with functional tumors, such as pheochromocytomas, insulinomas, and c …
Pheochromocytoma: presentation, diagnosis and treatment.
Reisch N, Peczkowska M, Januszewicz A, Neumann HP. Reisch N, et al. J Hypertens. 2006 Dec;24(12):2331-9. doi: 10.1097/01.hjh.0000251887.01885.54. J Hypertens. 2006. PMID: 17082709 Review.
Pheochromocytomas are rare, mostly benign catecholamine-producing tumors of chromaffin cells of the adrenal medulla or of a paraganglion. ...This review provides an update on identification and management of pheochromocytomas, emphasizing current developments in dia …
Pheochromocytomas are rare, mostly benign catecholamine-producing tumors of chromaffin cells of the adrenal medulla or of a paragangl …
Metastatic Pheochromocytomas and Abdominal Paragangliomas.
Granberg D, Juhlin CC, Falhammar H. Granberg D, et al. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e1937-e1952. doi: 10.1210/clinem/dgaa982. J Clin Endocrinol Metab. 2021. PMID: 33462603 Free PMC article. Review.
CONTEXT: Pheochromocytomas and paragangliomas (PPGLs) are believed to harbor malignant potential; about 10% to 15% of pheochromocytomas and up to 50% of abdominal paragangliomas will exhibit metastatic behavior. EVIDENCE ACQUISITION: Extensive searches in the PubMed …
CONTEXT: Pheochromocytomas and paragangliomas (PPGLs) are believed to harbor malignant potential; about 10% to 15% of pheochromocy …
2,811 results